Is Celestica The Best AI Stock to Buy Now?
Technology and hardware business Celestica (NYSE:CLS) has seen massive upward…
Sell
26
UNH Quote, Financials, Valuation and Earnings
Last price:
$281.59
Seasonality move
:
6.44%
Day range:
$280.60 - $286.22
52-week range:
$234.60 - $606.36
Dividend yield:
3.19%
P/E ratio:
21.00x
P/S ratio:
0.56x
P/B ratio:
2.67x
Volume:
10.5M
Avg. volume:
9.4M
1-year change:
-41.31%
Market cap:
$251.5B
Revenue:
$447.6B
EPS (TTM):
$13.19
Analysts' Opinion
-
Consensus RatingUnitedHealth Group, Inc. has received a consensus rating of Buy. The company's average rating is a Buy based on 15 Buy ratings, 6 Hold ratings, and 2 Sell ratings.
-
Price Target UpsideAccording to analysts' consensus price target of $362.54, UnitedHealth Group, Inc. has an estimated upside of 30.86% from its current price of $285.25.
-
Price Target DownsideAccording to analysts, the lowest downside price target is $255.00 representing 7.96% downside risk from its current price of $285.25.
Fair Value
-
According to the consensus of 23 analysts, UnitedHealth Group, Inc. has 30.86% upside to fair value with a price target of $362.54 per share.
UNH vs. S&P 500
-
Over the past 5 trading days, UnitedHealth Group, Inc. has underperformed the S&P 500 by -3.83% suggesting its relative strength compared to the major market average is weak at this time.
Share Buyback
-
UnitedHealth Group, Inc. does have a share repurchase program in place at this time. The scale of a buyback program can materially affect share price and usually results in a higher earnings per share, all else being equal, when the share count drops.
Revenue Growth
-
UnitedHealth Group, Inc. has grown year-over-year revenues for 145 quarters straight. In the most recent quarter UnitedHealth Group, Inc. reported revenues of $113.2B.
Earnings Growth
-
UnitedHealth Group, Inc. earnings have been falling on a year-over-year basis for 3 quarters in a row. In the most recent quarter UnitedHealth Group, Inc. reported earnings per share of $0.01.
Enterprise value:
342.1B
EV / Invested capital:
1.85x
Price / LTM sales:
0.56x
EV / EBIT:
23.27x
EV / Revenue:
0.76x
PEG ratio (5yr expected):
0.75x
EV / Free cash flow:
21.28x
Price / Operating cash flow:
15.71x
Enterprise value / EBITDA:
7.99x
Gross Profit (TTM):
--
Return On Assets:
4.13%
Net Income Margin (TTM):
2.86%
Return On Equity:
12.31%
Return On Invested Capital:
6.92%
Operating Margin:
0.34%
| Trailing 12 Months | Fiscal Quarters | |||||
|---|---|---|---|---|---|---|
| Period Ending | 2023-12-31 | 2024-12-31 | 2025-12-31 | 2024-12-31 | 2025-12-31 | |
| Income Statement | ||||||
| Revenue | $370.6B | $400.3B | $447.6B | $100.8B | $113.2B | |
| Gross Profit | -- | -- | -- | -- | -- | |
| Operating Income | $31.4B | $32.3B | $19B | $7.8B | $380M | |
| EBITDA | $36.3B | $28.1B | -- | $8.8B | -- | |
| Diluted EPS | $23.85 | $15.54 | $13.19 | $5.98 | $0.01 | |
| Period Ending | 2021-12-31 | 2022-12-31 | 2023-12-31 | 2024-12-31 | 2025-12-31 | |
|---|---|---|---|---|---|---|
| Balance Sheet | ||||||
| Current Assets | $61.8B | $69.1B | $78.4B | $85.8B | $90.6B | |
| Total Assets | $215.8B | $250.3B | $278.4B | $302.1B | $313.7B | |
| Current Liabilities | $78.3B | $89.2B | $99.1B | $103.8B | $114.9B | |
| Total Liabilities | $139.3B | $164B | $179.5B | $199.5B | $212B | |
| Total Equity | $76.5B | $86.3B | $98.9B | $102.6B | $101.7B | |
| Total Debt | $50.3B | $61.7B | $66.3B | $80.8B | $80.8B | |
| Trailing 12 Months | Fiscal Quarters | |||||
|---|---|---|---|---|---|---|
| Period Ending | 2023-12-31 | 2024-12-31 | 2025-12-31 | 2024-12-31 | 2025-12-31 | |
| Cash Flow Statement | ||||||
| Cash Flow Operations | $29.1B | $24.2B | $19.7B | $2.4B | $1.1B | |
| Cash From Investing | -$16.3B | -$20.8B | -$8.9B | -$1.4B | -$2.8B | |
| Cash From Financing | -$10.8B | -$3.2B | -$11.5B | -$8.1B | -$866M | |
| Free Cash Flow | $25.7B | $20.7B | $16.1B | $1.5B | $160M | |
UNH
Sector
Market Cap
$251.5B
$25.3M
Price % of 52-Week High
45.69%
48.74%
Dividend Yield
3.19%
0%
Shareholder Yield
3.89%
-1.64%
1-Year Price Total Return
-42.41%
-19.12%
Beta (5-Year)
0.406
0.492
Dividend yield:
3.19%
Annualized payout:
$8.73
Payout ratio:
20090.91%
Growth streak:
16 years
Technicals
8-day SMA
Sell
Level
$288.01
200-day SMA
Sell
Level
$314.84
Bollinger Bands (100)
Sell
Level
293.75 - 347.33
Chaikin Money Flow
Buy
Level
2.7B
20-day SMA
Sell
Level
$286.91
Relative Strength Index (RSI14)
Sell
Level
44.81
ADX Line
Sell
Level
29.02
Williams %R
Neutral
Level
-77.6691
50-day SMA
Sell
Level
$306.26
MACD (12, 26)
Sell
Level
-4.20
25-day Aroon Oscillator
Buy
Level
64
On Balance Volume
Neutral
Level
3.2B
Financial Scores
Hold
Altman Z-Score
(Annual)
Level (2.7614)
Sell
CA Score
(Annual)
Level (-0.5817)
--
Beneish M-Score
(Annual)
Level (--)
Sell
Momentum Score
Level (2)
Buy
Ohlson Score
Level (-0.5836)
Buy
Piotroski F Score
(Annual)
Level (5)
Sell
Quality Ratio Score
Level (1)
Buy
Fundamental Score
Level (7)
Revenue Forecast
Earnings per Share Forecast
Company Profile
UnitedHealth Group, Inc. engages in the provision of health care coverage, software, and data consultancy services. It operates through the following segments: UnitedHealthcare, OptumHealth, OptumInsight, and OptumRx. The UnitedHealthcare segment utilizes Optum's capabilities to help coordinate patient care, improve affordability of medical care, analyze cost trends, manage pharmacy benefits, work with care providers more effectively, and create a simpler consumer experience. The OptumHealth segment provides health and wellness care, serving the broad health care marketplace including payers, care providers, employers, government, life sciences companies, and consumers. The OptumInsight segment focuses on data and analytics, technology, and information to help major participants in the healthcare industry. The OptumRx segment offers pharmacy care services. The company was founded by Richard T. Burke in January 1977 and is headquartered in Eden Prairie, MN.
Stock Forecast FAQ
In the current month, UNH has received 15 Buy ratings 6 Hold ratings, and 2 Sell ratings. The UNH average analyst price target in the past 3 months is $362.54.
-
Where Will UnitedHealth Group, Inc. Stock Be In 1 Year?
According to analysts, the consensus estimate is that UnitedHealth Group, Inc. share price will rise to $362.54 per share over the next 12 months.
-
What Do Analysts Say About UnitedHealth Group, Inc.?
Analysts are divided on their view about UnitedHealth Group, Inc. share price and where it will be in the next 12 months. The majority of analysts rate the stock a Buy. However, a smaller subset of analysts suggest that UnitedHealth Group, Inc. is a Sell and believe this share price will drop from its current level to $255.00.
-
What Is UnitedHealth Group, Inc.'s Price Target?
The price target for UnitedHealth Group, Inc. over the next 1-year time period is forecast to be $362.54 according to 23 Wall Street analysts, 15 of them rate the stock a Buy, 2 rate the stock a Sell, and 6 analysts rate the stock a Hold.
-
Is UNH A Buy, Sell Or Hold?
According to Wall Street analysts, the consensus rating for UnitedHealth Group, Inc. is a Buy. 15 of 23 analysts rate the stock a Buy at this time.
-
How Can I Buy Shares Of UNH?
You can purchase shares of UnitedHealth Group, Inc. via an online brokerage firm such as TD Ameritrade.com, thinkorswim.com, e-trade.com, or Schwab.com. Many other digital online brokerages exist such as RobinHood and Webull where you can purchase UnitedHealth Group, Inc. shares.
-
What Is The UnitedHealth Group, Inc. Share Price Today?
UnitedHealth Group, Inc. was last trading at $281.59 per share. This represents the most recent stock quote for UnitedHealth Group, Inc.. Yesterday, UnitedHealth Group, Inc. closed at $285.25 per share.
-
How To Buy UnitedHealth Group, Inc. Stock Online?
In order to purchase UnitedHealth Group, Inc. stock online, open a brokerage account, deposit funds into the account, and select an order type to purchase shares whether it be market or limit.
Get UNH Stock Alert
Signup to receive the latest stock alerts
Financial Ratios
UNH
Sector
P/E ratio
21.00x
21.47x
PEG ratio
0.75x
-0.01x
P/B ratio
2.67x
1.74x
Price / LTM sales
0.56x
1.45x
Growth Metrics
UNH
Sector
Revenue growth
12.31%
3.36%
Earnings growth
-99.82%
11.93%
Revenue (5-year growth)
11.72%
6.25%
Earnings forecast
$2.11
-$0.20
Profitability
UNH
Sector
Profitability FY 2025
--
$2.2M
Return on invested capital
6.92%
-33.31%
Return on assets
4.13%
-29.82%
Return on equity
12.31%
-40.01%
Earnings Date
Last Earnings Date
Jan
27
Next Earnings Date
Apr
16
Estimated Next Earnings Date
Apr
28
Balance Sheet
UNH
Sector
Total cash
$32B
$24.9M
Short term investments
$3.8B
$23.2M
Total assets
$313.7B
$69.8M
Long term debt
$80.8B
$2.4M
SEE THE 1% OF STOCKS YOU NEED TO OWN FOR MASSIVE RETURNS
GET BETTER TRADE IDEAS
Popular
Will AI Disrupt SaaS Software Stocks?
Since January 28th, software stocks in the United States have…
Why Is Meta Stock Going Higher?
Over the last five days, shares of Instagram and Facebook…
Stock Ideas
Buy
54
Is NVDA Stock a Buy?
Market Cap: $4.5T
P/E Ratio: 37x
Sell
46
Is AAPL Stock a Buy?
Market Cap: $3.8T
P/E Ratio: 34x
Sell
40
Is GOOGL Stock a Buy?
Market Cap: $3.7T
P/E Ratio: 28x
Alerts
Buy
52
PZZA alert for Mar 13
Papa John's International, Inc. [PZZA] is down 6.43% over the past day.
Buy
53
NBIS alert for Mar 13
Nebius Group NV [NBIS] is up 0.83% over the past day.
Buy
88
NBTX alert for Mar 13
Nanobiotix SA [NBTX] is down 1.41% over the past day.
THE #1 STOCK ANALYSIS TOOL
TO MAKE SMARTER BUY AND SELL DECISIONS
Show me the best stock
